Department of Pediatric Pulmonology, Immunology and Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
National Centre of Pharmacoeconomics and Pharmacoepidemiology, Verona, Italy.
Pediatr Allergy Immunol. 2020 Jul;31(5):454-470. doi: 10.1111/pai.13271. Epub 2020 Jun 5.
The natural history of COVID-19 caused by SARS-CoV-2 is extremely variable, ranging from asymptomatic or mild infection, mainly in children, to multi-organ failure, eventually fatal, mainly in the eldest. We propose here the first model explaining how the outcome of first, crucial 10-15 days after infection, depends on the balance between the cumulative dose of viral exposure and the efficacy of the local innate immune response (natural IgA and IgM antibodies, mannose-binding lectin). If SARS-CoV-2 runs the blockade of this innate immunity and spreads from the upper airways to the alveoli in the early phases of the infections, it can replicate with no local resistance, causing pneumonia and releasing high amounts of antigens. The delayed and strong adaptive immune response (high-affinity IgM and IgG antibodies) that follows, causes severe inflammation and triggers mediator cascades (complement, coagulation, and cytokine storm), leading to complications often requiring intensive therapy and being, in some patients, fatal. Low-moderate physical activity can still be recommended. However, extreme physical activity and oral breathing with hyperventilation during the incubation days and early stages of COVID-19 facilitates re-inhalation and early direct penetration of high numbers of own virus particles in the lower airways and the alveoli, without impacting on the airway's mucosae covered by neutralizing antibodies ("viral auto-inhalation" phenomenon). This allows the virus to bypass the efficient immune barrier of the upper airway mucosa in already infected, young, and otherwise healthy athletes. In conclusion, whether the virus or the adaptive immune response reaches the lungs first is a crucial factor deciding the fate of the patient. This "quantitative and time-/sequence-dependent" model has several implications for prevention, diagnosis, and therapy of COVID-19 at all ages.
由 SARS-CoV-2 引起的 COVID-19 的自然史变化极大,从无症状或轻症感染(主要发生在儿童中)到多器官衰竭,最终死亡(主要发生在老年人中)。我们在这里提出第一个模型,解释感染后最初的 10-15 天的结果如何取决于病毒暴露的累积剂量与局部固有免疫反应(天然 IgA 和 IgM 抗体、甘露糖结合凝集素)的功效之间的平衡。如果 SARS-CoV-2 阻止了这种固有免疫,并在感染的早期阶段从上呼吸道扩散到肺泡,它就可以在没有局部抵抗的情况下复制,导致肺炎并释放大量抗原。随后发生的延迟和强烈的适应性免疫反应(高亲和力 IgM 和 IgG 抗体)会引起严重的炎症并引发介质级联反应(补体、凝血和细胞因子风暴),导致并发症,通常需要强化治疗,在某些患者中甚至是致命的。仍可推荐适度的身体活动。然而,在 COVID-19 的潜伏期和早期阶段,剧烈的身体活动和口呼吸伴过度通气会促进自身大量病毒颗粒重新吸入和早期直接穿透下呼吸道和肺泡,而不会影响被中和抗体覆盖的气道黏膜(“病毒自体吸入”现象)。这使得病毒能够绕过已感染的年轻且健康的运动员上呼吸道黏膜的有效免疫屏障。总之,是病毒还是适应性免疫反应先到达肺部是决定患者命运的关键因素。这种“定量、时间/顺序相关”的模型对 COVID-19 在所有年龄段的预防、诊断和治疗具有多方面的意义。